Add to ORKGEstrogen plus progestin increased long-term risk for invasive breast cancer in postmenopausal women Chlebowski RT, Anderson GL, Gass M, et al; WHI Investigators. Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. JAMA. 2010;304:1684-92. Clinical impact ratings: F★★★★★★ ✩ e★★★★★★✩ Question Does a combination of estrogen and progestin increase long-term risk for invasive breast cancer and breast cancer mortality
Ross et al. (1) report that women us-ing estrogen and progestin, compared with nonusers, have a 10 %...
Background:We examined if the reduced risk of breast cancer events seen among womenwithout baseline ...
Background: Prospective studies have consistently found that postmenopausal breast cancer risk incre...
Oestrogen plus progestin increased coronary heart disease and breast cancer in postmenopausal women ...
International audiencePURPOSETo investigate whether the relation between estrogen-progestagen menopa...
CONTEXT: Despite decades of accumulated observational evidence, the balance of risks and benefits fo...
Purpose: We and other investigators have previ-ously shown that postmenopausal combined estrogen and...
Several studies on hormone replacement therapy (HRT) in the USA have been published. They revealed t...
Comment on Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health I...
PURPOSE: Among unanswered questions is whether menopausal use of estrogen therapy (ET) or estrogen-p...
Breast cancer is the commonest cancer among women in the western world, accounting for up to 30% of ...
The population-based case–control study CECILE investigated the impact of various menopausal hormone...
between increased serum levels of estradiol and testosterone and breast cancer risk in postmenopausa...
TheWomen’s Health Initiative trial found a modestly increased risk of invasive breast cancer with da...
Three large clinical trials provoked major debate when hormone replacement therapy (HRT) did not red...
Ross et al. (1) report that women us-ing estrogen and progestin, compared with nonusers, have a 10 %...
Background:We examined if the reduced risk of breast cancer events seen among womenwithout baseline ...
Background: Prospective studies have consistently found that postmenopausal breast cancer risk incre...
Oestrogen plus progestin increased coronary heart disease and breast cancer in postmenopausal women ...
International audiencePURPOSETo investigate whether the relation between estrogen-progestagen menopa...
CONTEXT: Despite decades of accumulated observational evidence, the balance of risks and benefits fo...
Purpose: We and other investigators have previ-ously shown that postmenopausal combined estrogen and...
Several studies on hormone replacement therapy (HRT) in the USA have been published. They revealed t...
Comment on Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health I...
PURPOSE: Among unanswered questions is whether menopausal use of estrogen therapy (ET) or estrogen-p...
Breast cancer is the commonest cancer among women in the western world, accounting for up to 30% of ...
The population-based case–control study CECILE investigated the impact of various menopausal hormone...
between increased serum levels of estradiol and testosterone and breast cancer risk in postmenopausa...
TheWomen’s Health Initiative trial found a modestly increased risk of invasive breast cancer with da...
Three large clinical trials provoked major debate when hormone replacement therapy (HRT) did not red...
Ross et al. (1) report that women us-ing estrogen and progestin, compared with nonusers, have a 10 %...
Background:We examined if the reduced risk of breast cancer events seen among womenwithout baseline ...
Background: Prospective studies have consistently found that postmenopausal breast cancer risk incre...